Tactic Pharma LLC sold $35.0M of Monopar Therapeutics (MNPR)

Executed Sep 24 2025, disclosed Sep 26 2025, 2 days later.

Value, as filed

$35.0M

550,229 sh × $63.61

Executed

Sep 24 2025

the trade date, as filed

Disclosed

Sep 26 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TL Tactic Pharma LLC Chief Executive Officer profile →

Tactic Pharma LLC (Chief Executive Officer) filed 1 Form 4 report as a reporting entity in the trailing twelve months (0 purchases, 1 sale), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $35.0M of MNPR (550,229 sh × $63.61, as filed), executed Sep 24 2025.

The name

MNPR

Monopar Therapeutics Inc. MNPR · Healthcare · 11 filings in 24 months ticker →

Healthcare · Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Tactic Pharma LLC in MNPR

MNPRSALE Monopar Therapeutics Inc. $1.2M
33,334 sh × $35.00
Exec Apr 2 2025
Filed Apr 4 2025 · 5:30 PM ET